Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT
Marie Robin, Simona Iacobelli, Linda Köster, Jakob Passweg, Daniele Avenoso, Keith M. O. Wilson, Urpu Salmenniemi, Peter Dreger, Peter A. von dem Borne, John A. Snowden, Stephen D. Robinson, Maria Chiara Finazzi, Thomas Schroeder, Matthew Collin, Matthias Eder, Édouard Forcade, Michaël Loschi, Stéfania Bramanti, José Antonio Pérez‐Simón, Tomasz Czerw, Nicola Polverelli, Joanna Drozd‐Sokołowska, Kavita Raj, Juan Carlos Hernández‐Boluda, Donal P. McLornan
Topics & Concepts
MedicineBusulfanInternal medicineTreosulfanMyelofibrosisTransplantationHematopoietic stem cell transplantationOncologyCohortProportional hazards modelCumulative incidenceProspective cohort studySurgeryGastroenterologyBone marrowMyeloproliferative Neoplasms: Diagnosis and TreatmentAcute Myeloid Leukemia ResearchChronic Myeloid Leukemia Treatments